Cholesterol-Lowering Gene Therapy Prevents Heart Failure With Preserved Ejection Fraction in Obese Type 2 Diabetic Mice

International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms20092222
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Heart Failure With Preserved Ejection Fraction: Can Device Therapy Be Our Option?

Cureus
2020English

Prognosis of Heart Failure With Stable Mid-Range Ejection Fraction in Comparison to Heart Failure With Stable Reduced Ejection Fraction and Heart Failure With Stable Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2019English

Influence of Ejection Fraction on Cause-Specific Mortality in Heart Failure With Preserved Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Phosphodiesterase-5 Inhibition in Heart Failure With Preserved Ejection Fraction: Trading Therapy for Prevention

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Time to Scrutinize Diuretic Therapy?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Molecular and Pathophysiological Links Between Heart Failure With Preserved Ejection Fraction and Type 2 Diabetes Mellitus

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy